問題: 薬と健康

Intelligence medical research

+1  

Use the intelligence agencies as a trusted partner to conduct health research based on private health histories and genetic data.

YAML 発想

There is a conundrum in medical research -- the genetic and detailed data is inevitably personally identifying, and so, it's hard to share and compute with (homomorphic encryption may solve this, but I don't know of exactly how at this point).

However, the society could benefit immensely from personal medical histories and genetic data.

So, being a rather neutral party, not interested in profiting from the health insurances or otherwise from customers, the intelligence agencies could actually be useful as a party that legally is permitted to conduct the research with such private and personal data.

Btw., examples of companies illegally obtaining such data exist, e.g., [link].

Mindey,

(通知しない) (不必要) ログインしてください。

もちろん、人々はOAuthを使用してデータに同意する必要がある、または暗号化と許可付きのトークン化分散コンピューティングが必要であるというコメントがあります。もちろん私はこれらの方法を知っていますし、病院がそれらの標準的な方法でデータを管理できたら素晴らしいと思います。ただし、ケースバイケースで同意を求めるよりも効率的であるため、社会的価値と引き換えに政府に権利を与えることで人々が行う一定の同意があります。

このアイデアが提案しているのは、老化と死が私たち全員の共通の敵であるため、そのような医学研究はそのようなケースの1つであるということです-デフォルトでこれに体系的かつ大規模に協力することで、パターンと最良の治療戦略を迅速に発見できました。リスクはおそらく、治療された病気の増加に対するプライバシーの余分な損失のコストと、結果としてより長く生きた人々の寿命として推定されるべきです。

Of course, there will be comments saying, that people should have to consent to their data, using OAuth, or cryptography and tokenomic decentralized computing with permissioning. I'm of course aware of these methods, and it would be great if hospitals managed their data in those standard ways. However, there are certain consents that people do through giving rights to governments in exchange for social value, because it's more efficient than asking for consents on a case-by-case basis.

What this idea is proposing, is that such medical research is one of such cases, because aging and death is the common enemy of us all -- we could quickly discover patterns of and best treatment strategies by systematically and massively cooperating for this by default. The risk perhaps should be estimated as the cost of extra loss of some privacy to the gain in treated diseases and life years of people survived longer as a result.